Trials / Completed
CompletedNCT03788031
Perceptual Learning Treatment for Amblyopia
Towards Developing a Perceptual Learning Treatment for Amblyopia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Accepted
Summary
Objectives. To develop a new treatment for amblyopia using a perceptual learning approach. Hypothesis to be tested. Our proposed experiments are designed to investigate whether practicing a grating detection task can improve vision in patients with amblyopia. Design and subjects. A total of 36 patients with amblyopia will be randomized allocated into two intervention groups: Group 1, perceptual learning therapy. Group 2, occlusion therapy. A control group comprising of 18 subjects with normal vision will be recruited for comparison. A battery of tests will be used to assess a range of visual functions before and after the treatment intervention. Study instruments. Grating acuity testing system Interventions. We have established a clinical protocol for acuity training. On each trial, a properly oriented stimulus will be presented randomly at one of the four locations on a flat monitor screen. The visual task is to indicate the location of the stimulus. Participants will be required to undertake 20 one-hour sessions of training. Main outcome measures. Resolution acuity, visual acuity, contrast sensitivity function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Acuity training | The intervention will be a vision therapy. On each trial, a properly oriented stimulus will be presented randomly at one of the four locations on a flat monitor screen. The visual task is to identify the location of the stimulus. |
| OTHER | Occlusion therapy | Participants will be required to patch the good eye for 20 days, 1 hour per day. |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2022-12-31
- Completion
- 2023-02-28
- First posted
- 2018-12-27
- Last updated
- 2024-08-29
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT03788031. Inclusion in this directory is not an endorsement.